Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Ringel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biological Reviews of the Cambridge Philosophical Society|December 10, 2025
Why we ageMichael S Ringel
Nature Reviews. Drug Discovery|July 8, 2017
What is the right amount to spend on biopharma R&D?Michael S Ringel
Drug Discovery Today|June 25, 2017
Do large mergers increase or decrease the productivity of pharmaceutical R&D?Michael S Ringel, Michael K Choy
Nature Reviews. Drug Discovery|January 18, 2022
2021 FDA approvals: value driven by COVID-19 vaccinesMathias Baedeker, Michael S Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 17, 2025
2024 FDA approvals exceed average number but have lower sales projectionsMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Aging|October 6, 2025
Accelerating activity in the longevity biopharmaceutical sectorMichael S Ringel, Yue Zhang, Wen Kin Lim
Nature Reviews. Drug Discovery|January 17, 2024
2023 FDA approvals: unprecedented volume at moderate valueMathias Baedeker, Michael S Ringel, Clemens C Möller
The Hastings Center Report|June 25, 2025
Why We Can Thrive past Seventy-Five: In Favor of Efforts to Extend the Human LifespanCarolyn B Ringel, Michael S Ringel, Arthur L Caplan
Nature Reviews. Drug Discovery|April 18, 2020
Breaking Eroom's LawMichael S Ringel, Jack W Scannell, Mathias Baedeker, et al.
Clinical Pharmacology and Therapeutics|January 14, 2019
Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence GenerationMyrto Lee, Hoan Ly, Clemens C Möller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biological Reviews of the Cambridge Philosophical Society|December 10, 2025
Why we ageMichael S Ringel
Nature Reviews. Drug Discovery|July 8, 2017
What is the right amount to spend on biopharma R&D?Michael S Ringel
Drug Discovery Today|June 25, 2017
Do large mergers increase or decrease the productivity of pharmaceutical R&D?Michael S Ringel, Michael K Choy
Nature Reviews. Drug Discovery|January 18, 2022
2021 FDA approvals: value driven by COVID-19 vaccinesMathias Baedeker, Michael S Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 17, 2025
2024 FDA approvals exceed average number but have lower sales projectionsMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Aging|October 6, 2025
Accelerating activity in the longevity biopharmaceutical sectorMichael S Ringel, Yue Zhang, Wen Kin Lim
Nature Reviews. Drug Discovery|January 17, 2024
2023 FDA approvals: unprecedented volume at moderate valueMathias Baedeker, Michael S Ringel, Clemens C Möller
The Hastings Center Report|June 25, 2025
Why We Can Thrive past Seventy-Five: In Favor of Efforts to Extend the Human LifespanCarolyn B Ringel, Michael S Ringel, Arthur L Caplan
Nature Reviews. Drug Discovery|April 18, 2020
Breaking Eroom's LawMichael S Ringel, Jack W Scannell, Mathias Baedeker, et al.
Clinical Pharmacology and Therapeutics|January 14, 2019
Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence GenerationMyrto Lee, Hoan Ly, Clemens C Möller, et al.
Pageof 2